Genetic Signatures Ltd.ASX: GSS

Update on Commercial Terms for Proposed Merger with MAP

· Issued by Genetic Signatures Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The revised terms indicate that Microba shareholders will hold a larger percentage of the merged entity than previously stated, while existing Genetic Signatures shareholders will hold a smaller percentage. All other material terms of the merger remain unchanged and the transaction is progressing as planned.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/update-on-commercial-terms-for-proposed-merger-with-map

Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call

Release

ASX Announcement 21 October 2026 Update on Commercial Terms for the Proposed Merger with Microba Life Sciences • Genetic Signatures Limited (ASX: GSS) (GSS) and Microba Life Sciences Limited (ASX: MAP) (Microba) have agreed, in principle, to revised terms for the proposed merger, under which...

Genetic Signatures Ltd. on 6ix

Story so far

Earlier from Genetic Signatures

Later from Genetic Signatures

All Genetic Signatures news releases